Abstract
This study explored whether telephone-delivered mindfulness training (MT) to promote medication adherence and reduce sexual risk behavior was feasible for and acceptable to people living with HIV. Participants (N = 42; 50% female; M age = 47.5 years) were randomized to MT or health coaching (HC). Pre- and post-intervention, and at 3-month follow-up, we assessed adherence to ART, sexual risk behavior, and hypothesized mediators; we also conducted individual interviews to obtain qualitative data. Results showed that 55% of patients assigned to MT completed ≥ 50% of the training calls compared with 86% of HC patients (p < .05). Most patients reported satisfaction with their intervention (MT = 88%, HC = 87%). Patients in MT and HC reported improvements in medication adherence, mindfulness, and sexual risk reduction as well as reductions in anxiety, depressive symptoms, perceived stress, and impulsivity over time; however, no between-groups differences were observed.
Resumen
Este estudio exploró si el entrenamiento de atención plena (MT) impartido por teléfono para promover la adherencia a los medicamentos y reducir el comportamiento de riesgo sexual era factible y aceptable para las personas que viven con el VIH (PVVS). Los participantes (N = 42; 50% mujeres; edad M = 47.5 años) fueron asignados al azar a MT o entrenamiento de salud (HC). Antes y después de la intervención, y a los 3 meses de seguimiento, evaluamos la adherencia a medicación antirretroviral, el comportamiento de riesgo sexual y los mediadores hipotetizados; También realizamos entrevistas individuales para obtener datos cualitativos. Los resultados mostraron que el 55% de los pacientes asignados a MT completaron ≥ 50% de las llamadas de entrenamiento en comparación con el 86% de los pacientes con HC (p < .05). La mayoría de los pacientes reportaron satisfacción con su intervención (MT = 88%, HC = 87%). Los pacientes en MT y HC reportaron mejoramiento en la adherencia a la medicación, la atención plena y la reducción del riesgo sexual, y también reducciones en la ansiedad, los síntomas depresivos, el estrés percibido y la impulsividad al transcurso del tiempo; sin embargo, no se observaron diferencias entre grupos.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Antiretroviral therapy (ART) improves viral suppression, reduces infectiousness and HIV-related morbidities, and increases survival for people living with HIV (PLWH) [1,2,3]. Despite the benefits of ART, medication adherence can be challenging [4, 5]. One of the strongest predictors of non-adherence is life stress [6,7,8]. Living with HIV can be stressful for many reasons including its uncertain course, the need for lifelong care, and the cost of HIV care. Additional stress can result from disease-related stigma [9]. Moreover, because HIV in the U.S. is most prevalent among racial, ethnic, and sexual minorities, PLWH often experience minority stress and discrimination [10] and are more likely to be economically disadvantaged [11, 12]. Collectively, these life stressors can increase impulsivity [13] and depression [14] as well as alcohol and other substance use [15, 16], factors that can undermine medication adherence.
Psychosocial stress also affects other health behaviors, such as sleep, physical activity, and safer sexual practices. Safer sexual practices, including condom use, are especially important for PLWH because protective behaviors lower the risk of transmitting HIV to an uninfected partner as well as the risk of acquiring other sexually transmitted infections (STIs). However, some PLWH often report condomless sex at their last sexual encounter [17, 18]. One way to improve health behaviors, including medication adherence and safer sexual behaviors, is to help PLWH cope with psychosocial stress.
Among extant stress management practices, mindfulness training (MT) has received widespread attention. Indeed, scientific publications and news media articles on mindfulness and meditation have grown exponentially over the past two decades [19, 20]. Although the term “mindfulness” has been used to refer to a large number of practices, herein we use it to refer to interventions that seek to cultivate a particular way of paying attention to the present moment’s experience (“on purpose and non-judgmentally”) [22]. Previously, we presented a conceptual model by which MT may help PLWH achieve better adherence to ART [21]. In our model, we suggested that MT could help PLWH to improve appraisal and coping processes; these benefits, in turn, could then help to reduce distress and make it easier to follow medical recommendations, including adherence to ART and safer sex behavior [21].
Empirical evidence provides preliminary support for the value of MT. Meta-analyses show that MT can reduce anxiety, distress, and symptoms of depression among patients with chronic illnesses, including HIV [22]. Several studies have examined the effects of MT on immune functioning among PLWH [23,24,25] and preliminary results are encouraging [26]. However, to our knowledge, no study has investigated MT as a way to enhance medication adherence. In addition, many published studies of MT for PLWH have several methodological limitations (e.g., failure to use rigorous control or comparison conditions, to match homework and daily practice, and to match expertise and confidence of the instructors) [27]. Research that targets medication adherence specifically while addressing the methodological limitations of prior research is needed.
In addition, as a practical matter, traditional approaches to MT (i.e., in person workshops) are limited by the need to attend extensive sessions. Because many PLWH report unstable housing, lack of access to reliable transportation, poor access to internet resources, and family and work responsibilities that can prevent them from attending in-person interventions, a delivery mode of MT that has fewer barriers would be more practical for PLWH.
Telephone-delivery can help to reduce barriers associated with face-to-face interventions. Telephone-delivery also allows more individualized training compared to traditional, group-based MT. The feasibility of telephone delivery was suggested by pilot data that indicated that nearly all PLWH, even those with severe financial hardship, had access to mobile telephones [28]. We were also encouraged by the demonstrated feasibility and acceptability of telephone-delivered MT with other patient populations [29, 30].
The primary purpose of this exploratory trial was to determine the feasibility and acceptability of telephone-delivered MT for PLWH. We set quantitative benchmarks for feasibility and acceptability consistent with guidelines from the National Center for Complementary and Integrative Health (NCCIH), which recommends that such benchmarks be relevant to the specific treatment conditions and population under study. For the current study, we proposed that ≥ 70% of patients attending ≥ 50% of the intervention sessions provide evidence that MT was feasible. We also expected high levels of acceptability; thus, we set a benchmark of ≥ 80% of patients reporting positive satisfaction with MT.
A secondary purpose of the study was to collect evidence regarding the effect of MT for medication adherence and sexual risk reduction. We expected that, compared to a time- and attention-matched control intervention, MT would improve ART adherence and reduce sexual risk behaviors. In addition, we sought to gauge the effects of MT on possible mediators of MT; (i.e., mindfulness, anxious and depressive symptoms, perceived stress, impulsivity). We expected that MT would improve mindfulness and reduce negative affect, perceived stress, and impulsivity.
Methods
Design
Details on the study design have been published elsewhere [31]. Briefly, we used a parallel-group, randomized clinical trial design. After completing the baseline assessments, patients were randomized to receive either telephone-delivered MT or telephone-delivered health coaching (HC), which served as a time- and attention-matched control condition. We reassessed patients at post-intervention and at a three-month follow-up.
Participants
The sample was recruited at a hospital-based HIV clinic in the northeastern United States.
Inclusion criteria were: (a) ≥ 18 years of age; (b) infected with HIV; (c) sub-optimally adherent to ART based on self-reported medication lapses and/or chart recorded viral load of > 20 copies/mL; (d) sexually active (past 3 months); (e) self-reported psychological distress; and (f) access to a landline telephone or mobile phone.
Exclusion criteria were (a) cognitive impairment or other contraindication to enrollment in a research study according to their clinic provider; (b) non-English speaking; (c) lower literacy (i.e., reported they often or always needing someone to read instructions or other written materials from a doctor or pharmacy to them); (d) enrolled in another behavioral research study; (e) prior MT or practice of mindfulness or related mind–body techniques; (f) hearing impairment that would interfere with telephone delivery; (g) suicidal ideation; and (h) planning to move out of the geographic area within the study period.
Measures
All behaviors and constructs were assessed using measures validated in previous research. Assessments were conducted at baseline, post-intervention, and 3 months post-intervention.
Participant Characteristics
At baseline, we assessed demographic characteristics (i.e., age, gender, income, educational level, employment status), perceived social support (MSPSS) [32], alcohol misuse (AUDIT) [33], drug use (DAST) [34], and medical history (i.e., date of HIV diagnosis, length of time since initiating ART, VL and CD4 counts, adherence to medical appointments, number of HIV-related hospitalizations, medical and psychiatric comorbidities, and current medications).
Primary Outcomes
The primary outcomes were feasibility and acceptability.
Feasibility Metrics of feasibility included recruitment, retention, and session attendance. Participants were also asked a series of questions during a qualitative interview (e.g., “Were the telephone calls and the schedule acceptable? Did you miss any sessions and, if so, why?”).
Acceptability To assess the acceptability of the interventions, patients completed a validated survey [35] on which they rated the quality of and satisfaction with the MT or HC, whether it improved their health, if they would recommend to a friend, if they received the intervention they wanted, and their overall level of satisfaction. In addition, patients were asked a series of questions during the qualitative interviews (e.g., “What was most helpful/least helpful about the sessions?” “Did you notice any benefits or problems?”).
Secondary Outcomes
The secondary outcomes were medication adherence and sexual risk behaviors.
Medication adherence Consistent with recommendations [36], adherence was assessed using a multi-modal approach (self-report, an objective measure, and a biomarker).
Self-reported adherence was obtained using a validated measure developed through extensive cognitive testing [37]. Patients were asked to respond to the item that had been shown to be the least likely to produce a ceiling effect in the validation study, namely: “In the last 30 days, on how many days did you miss at least one dose of any of your HIV medicines?” Patients provided a numerical response that could range from 0 to 30.
The objective measure of adherence was obtained during unannounced telephone-based pill counts, which have been shown to be reliable and valid [38,39,40]. Consistent with validated protocols [39], calls were conducted for 2 months prior to the intervention to establish a stable baseline. Thereafter, calls continued monthly on an unannounced basis for the remainder of the study. Calls were conducted by trained assessors working in the laboratory of the originator of this assessment protocol.
The biomarker was HIV viral load (HIV-1 RNA copies/mL). Because there is no universally accepted threshold for viral suppression (i.e., investigators have used values ranging from 50 to 1000 copies/mL) [41], we chose to operationalize viral suppression with a middle value of < 500 copies/mL level. Blood samples were collected at baseline, post-intervention, and follow-up via phlebotomy and processed using standard procedures.
Sexual risk behaviors. Information was collected using both self-reported and objective assessments. Participants were asked to report their sexual behavior for the past 3 months. For each partner, they reported the partner’s gender, relationship type (regular, other), types of sex (anal, vaginal, and oral), number of times for each type of sex, and number of times a condom was used for each type of sex. Their responses allowed us to calculate the total number of condomless events. We provided definitions of all terms and used items that we and many others have used in sexual risk reduction research [42].
As an indirect but objective measure of risk behavior we tested for (a) Neisseria gonorrhoea (NG), Chlamydia trachomatis (CT), and Trichomonas vaginalis (women) using nucleic acid amplification testing (NAAT) of urine specimens, (b) pharyngeal and rectal NG and CT using NAAT from swabs at these sites, and (c) syphilis serologies using blood specimens. Because point-prevalence testing does not capture STIs that have been treated between visits, we also abstracted information about STI incidence from the medical record.
Tertiary Outcomes
We assessed five hypothesized mediators [21] using brief measures that had been used in prior studies with PLWH.
Anxiety was measured with the 7-item Generalized Anxiety Disorder (GAD) scale [43]. A sample item is “Over the last 2 weeks, how often have you been bothered by feeling nervous, anxious, or on edge?” Response options ranged from 0 = not at all to 3 = nearly every day, with total scores ranging from 0 to 21.
Depression was assessed using the 9-item Patient Health Questionnaire (PHQ) [44]. A sample item is “Over the last 2 weeks, how often have you been bothered by feeling down, depressed or hopeless?” Response options ranged from 0 = not at all to 3 = nearly every day, with total scores ranging from 0 to 27.
Perceived stress was measured with the 4-item Perceived Stress Scale (PSS) [45]. A sample item is “In the last 30 days, how often have you felt difficulties were piling up so high that you could not overcome them?” Response options ranged from 0 = never to 4 = very often, with total scores ranging from 0 to 16.
Mindfulness was assessed using the 15-item Five Facets of Mindfulness Questionnaire (FFMQ) [46]. A sample item is “I pay attention to sensations, such as the wind in my hair or sun on my face.” Response options ranged from 1 = never to 5 = very often or always true, with total scores ranging from 15 to 75.
Impulsivity was measured using the 8-item version of the Barratt Impulsiveness Scale (BIS) [47]. A sample item is “I do things without thinking.” Response options ranged from 1 = never to 4 = almost always, with total scores ranging from 8 to 32.
All measures have been psychometrically-evaluated and shown to be reliable and valid in prior research. They were administered using published instructions and response options. For all measures, we summed across items as recommended to obtain a total score. Items were reverse scored when indicated such that higher scores indicate more of the construct being measured.
Procedures
All procedures were approved by the Institutional Review Board of the hospital.
Screening
We first conducted a preliminary review of the clinic medical records to identify patients who (a) had a detectable HIV-1 plasma viral load (VL) within the past 12 months, (b) were ≥ 18 years of age, and (c) had a clinic visit planned within the next 3 months. We also distributed flyers to clinic providers asking them to refer potentially eligible patients. We did not screen patients if their physician indicated that they were cognitively impaired and unable to participate meaningfully in the research.
Potentially eligible patients were approached in person by the project director (PD) or a research assistant (RA) at a clinic visit. The PD or RA obtained verbal consent to conduct a brief screening interview to determine eligibility. A script and survey were used to standardize screening. During the screening, we assessed ART adherence (eligible if < 100% adherent during the past 6 months), psychological distress (eligible if scoring ≥ 2 on the PHQ-4), sexual risk behavior (eligible if reporting any condomless sex and/or > 1 sexual partner in the past 6 months), and telephone access (eligible if they had access). We also screened for, and excluded, patients who reported prior training in mindfulness, meditation, or related mind–body techniques (past year), hearing impairment, suicidal thoughts, plans, or attempts during the past month [48], low literacy (unable to read at a ≥ 6th grade level) [49].
Recruitment and Consent
Eligible patients were informed about the study purpose, procedures, risks, and benefits and if interested, they were asked to provide written informed consent. Participants were compensated for their time by receiving a modest stipend.
Baseline Visit
The baseline visit involved four components: (1) completing a survey on a laptop computer in a private exam room, (2) providing a bio-specimen later tested for VL and STIs, (3) receiving instruction regarding the telephone-based, unannounced pill count assessment, and (4) providing contact information.
Randomization
Participants were randomly assigned (1:1 ratio) to either MT or the HC condition using a permuted block randomization procedure with small, random-sized blocks generated by the study biostatistician.
Blinding
MT instructors and HC coaches were blinded to the study hypotheses. Adherence assessors were blinded to treatment allocation and study hypotheses.
Interventions
The intervention began 2 months after the baseline visit (i.e., after the completion of 2 months of unannounced pill counts). Participants in both conditions were told that they would receive a scheduled telephone call each week for 8 weeks lasting 30 min. Patients were encouraged but not required to accept the intervention telephone call in a quiet place, such as in their home.
To avoid contamination, different individuals delivered the MT and HC intervention. MT instructors were two female graduates of the teachers’ training program at the University of Massachussetts Center for Mindfulness with ≥ 5 years teaching experience. Health coaches were two clinical psychology residents (one male and one female) with 5 years of clinical training. Both the MT instructors and the health coaches received 3 h of study-specific training that involved reading and reviewing the intervention protocols as well as discussing telephone-delivery, record keeping, and communicating with participants.
To ensure that interventions were delivered with fidelity, interventionists followed a written protocol for each session; however, they were allowed to use specific phrasings and examples that were consistent with their style and experience. The interventionists received supervision from the investigators weekly during the first month of the study, biweekly during the second month, and monthly thereafter. For both conditions, we assessed treatment fidelity following the Treatment Fidelity Workgroup guidelines [50]. Thus, instructors audio-recorded each session (instructor’s voice only) and the investigators audited 10% of all recordings using a checklist of intervention components. Features unique to each intervention are described next.
Mindfulness training (MT) This intervention maintained the basic components of Mindfulness-based Stress Reduction (MBSR [51]) but was streamlined to distill the active ingredients for telephone delivery [31]. The intervention included three basic components: (1) the body scan, a technique based on the cultivation of attention to bodily sensations; (2) awareness of breath, in which participants are taught to focus their attention on the sensations of breathing; (3) open awareness, in which they were instructed to just notice which event (e.g., physical sensation, sound, visual object, and/or thought) their attention was spontaneously drawn to from moment to moment. In addition, participants were trained to direct their attention to activities of daily life (e.g., eating, drinking, driving), sounds, visual objects, thoughts, and emotions and to recognize when their attention was no longer focused on that specific object of attention. Patients did not receive materials usually provided to MBSR trainees in the form of poetry or other readings. Likewise, they did not practice hatha yoga exercises due to the impossibility to monitor the correctness of the yoga postures over the telephone, which could expose them to risk of muscular strains and skeletal injuries. In addition to the weekly training session, patients were instructed to practice mindfulness techniques for 15 min daily using an audio recording that guided them through the techniques learned with their instructor [29]. The recording was provided in a format (e.g., CD, MP3 file) that the participant preferred. These and other minor adaptations were made based on input from focus groups conducted with HIV patients, providers, and community advocates [28].
Health coaching (HC) The HC condition consisted of educational modules designed to control for the contact time and attention received in the MT condition. The topics (i.e., nutrition, sun safety, physical activity, sleep, home and travel safety) were chosen based on input from focus groups conducted with HIV patients, providers, and community advocates [28]. Educational content was adapted from published, empirically-based recommendations (e.g., the American Heart Association [52]). Importantly, HC did not address ART adherence or safer sexual behavior or their possible determinants (i.e., anxiety, depression, impulsivity, perceived stress, mindfulness).
To match the time MT patients spent doing mindfulness exercises at home, HC patients were assigned a 15-minute daily activity that aligned with the coaching topics (e.g., keeping a sleep diary, trying healthy foods).
Post-intervention Assessment
The post-intervention assessment occurred within 2 weeks of the last scheduled intervention call. Participants returned to the clinic to complete the survey, provide biospecimens for testing, and take part in a brief, semi-structured qualitative interview. The qualitative assessment addressed the following topics: study procedures, most/least helpful intervention content, use of home practice materials (i.e., mindfulness recordings or health coaching workbook), and ability to complete study, including the acceptability of the telephone delivery of the study content.
Follow-up Assessment
The follow-up assessment occurred 3 months (± 2 weeks) after the last scheduled intervention call. Participants returned to the clinic to complete the survey, provide biospecimens for testing, and take part in a brief, semi-structured qualitative interview. The qualitative assessment addressed changes since completing the study, thoughts regarding study compensation, and continued use of mindfulness or health coaching skills.
Data Analyses
Preliminary analyses examined equivalence of the MT and HC groups at baseline on demographic and other characteristics using Fisher, t tests or Mann–Whitney depending on the level of measurement (i.e., categorical or continuous) and the distribution (i.e., normal or skewed) of the variables. We examined the distributional properties of continuous variables to determine if normalizing transformations should be applied before conducting analyses.
Primary Outcomes
We calculated the percentage of individuals who were eligible; consented; accepted randomization; and returned for the post-intervention and 3-month follow-up assessments. We calculated session attendance for both conditions and the percentage of individuals who completed at least half of the training sessions. To determine the acceptability of the interventions, we calculated means for the satisfaction surveys.
Secondary and Tertiary Outcomes
This was an exploratory study; therefore, it was not powered to detect treatment effects or to formally test mediation. Therefore, we examined both within- and between-group effects on ART adherence and sexual risk behavior as well as on each of the posited mediators.
Qualitative Analyses
Recordings of the interviews were reviewed and recorded in a standardized written debrief and summary form and included direct quotations of relevant passages. Thematic and comparative analyses were conducted using NVivo [53]. Qualitative data were sorted and reviewed both in aggregate and also based on call completion rates, to identify themes specifically related to the acceptability of the telephone-delivered intervention format. Throughout the coding and analysis process, categories and subcategories were compared and revised as new information was considered and as we came to new understandings of the data.
Results
Baseline Characteristics
Table 1 displays the participants’ characteristics (overall and by condition) at baseline. The final study sample (N = 42) was 50% female and ranged in age from 24 to 68 years (M = 47.5; SD = 11.3); 24 patients (57%) identified as racial/ethnic minorities and 18 (43%) identified as White. Overall, randomization produced similar groups. There were no differences in sex, gender identity, age, race, ethnicity, educational level, current finances, social support (MPSS), alcohol misuse (AUDIT), or drug use (DAST). The only significant between-groups difference was employment status, with those in the MT group more likely to be unemployed or retired.
Feasibility
As shown in Fig. 1 (consort diagram), after reviewing the medical records of 297 patients, we screened 128 PLWH. Of these, 69 (54%) were eligible and 50 (72%) enrolled. However, six patients were lost prior to randomization and two patients were randomized but never started the intervention leaving a final analytic sample of 42 patients.
As displayed in Fig. 1, 17/20 (85%) patients in the MT condition and 22/22 (100%) of those in the HC returned for the post-intervention assessment. Attendance at the follow-up assessment was 100% for both conditions.
As shown in Table 2, 55% (11/20) of the patients in the MT condition and 86% (19/22) of those in the HC condition attended ≥ 50% of the planned calls. Neither the mean of sessions attended (MT = 4.55, HC = 5.64) nor the proportion of weeks with rescheduled calls (MT = .52, HC = .51) differed between conditions (ps> .10).
Regarding individual home practice, MT patients reported they practiced (both with and without the audio files we provided) on 3.4 days/week, with an average of 12 min per home practice session. HC patients reported engaging in practice on 4.5 days/week, with an average of 12 min/day.
Qualitative data Patient reports about the MT were mixed. Some patients reported that the telephone-delivered MT was convenient and flexible, whereas others were not able to fully participate in calls or do their home practice due to life stress. Others noted that it was not always convenient to be in a quiet place (e.g., at home) to receive the calls. Among the nine patients who completed fewer than 50% of MT sessions, four stated the study was helpful and four reported continued use of the mindfulness audio files at follow-up despite minimal completion of intervention calls. Specific reasons for missing calls included life stress (n = 4), dislike of mindfulness training (n = 1), dislike of the study in general (n = 1), scheduling problems (n = 1), and a preference for in-person training (n = 1).
Reports about HC were more consistently positive. Most patients reported that the telephone delivery was flexible and rescheduling occurred “seamlessly.” Patients reported that the health-related information was helpful, while others reported that the intervention was “lengthy” and would have preferred a shorter program.
Some patients reported concerns related to confidentiality and privacy. One patient reported difficulties engaging in the study calls due to fears about inadvertent disclosure of his HIV status. Another patient noted that pill counts were challenging because the patient removed labels from pill bottles to prevent others from identifying the medications. Some patients also thought that the pill count calls were part of the study intervention.
Acceptability
As seen in Table 3, ratings for both interventions exceeded the a priori standard for acceptability (i.e., ≥ 80% of patients reporting positive satisfaction ratings). Thus, we concluded that both interventions were acceptable to patients.
However, greater satisfaction was reported by patients who received HC. Relative to patients who received MT, patients who received HC were more likely to rate the quality of their experience as excellent (HC = 86%, MT = 53%; p < .05). Though not statistically significant, HC patients were more likely to report they would definitely recommend the intervention to a friend (HC = 77%, MT = 59%), and to report being very satisfied with the amount of coaching received (HC = 82%, MT = 53%) and their assigned intervention overall (HC = 64%, MT = 47%).
Qualitative data Patients found our recruitment methods (i.e., in-person, by telephone and mail outreach) acceptable; their experiences with MT were varied. Although some patients reported initial hesitation regarding MT, many found themselves coming to enjoy it and to engage in daily practice; for example, one patient stated: “this is something I didn’t expect in the beginning but I am so glad I was able to take part in this study [and learn mindfulness] because it has helped me on so many levels.” Participants reported positive experiences with mindfulness and their instructors, reporting “I am more relaxed, more focused, I find myself going back to [name of instructor]…I find myself going back in and doing the things that [instructor] taught me to do…the sitting still, paying attention to your body, just sitting still and listening.” In contrast, one patient reported discomfort sitting in silence and focusing attention.
Reports about HC were more consistently positive. Several patients described the program as “pretty amazing” and appreciated the positive interactions with health coaches. One participant noted “I loved it. I think it helped me tremendously to take care, better care of myself. I would recommend it, and I would enjoy to continue to have it. Definitely a good experience.” Patients thought the study was about overall health related to living with HIV. For example, a HC participant described the study as “helping us to keep it together. I mean, because a lot of the time we don’t think about those things because we are stuck on ‘when am I going to die?’ And you can’t do that, you have to think about life!”
Adherence
Self-report Patients reported modest declines in the number of “missed days” from baseline through follow-up (Table 4). The number of days in which patients missed at least one medication dose decreased in the MT group (baseline = 4.2, post-intervention = 3.4, follow-up = 2.7) and in the HC group [Means (Ms) = 1.9, 1.6, 1.5]. We did not observe a time-by-condition interaction for self-reported medication adherence, F (2, 80) = 0.21, p = .809.
Unannounced pill counts Unadjusted average adherence scores at each measurement point are presented in Table 4. To ease interpretation, we averaged data from the two intervention phase intervals to create a single adherence measure during intervention; similarly, we averaged data from the follow-up intervals. The unadjusted average adherence composite scores at baseline, during intervention, and during follow-up are presented by group in Fig. 2. Average adherence for the HC group ranged from 81% at baseline to 76% during the intervention and 80% at follow-up; for the MT group, adherence ranged from 85% at baseline to 74% during the intervention and 82% post-intervention. Mixed effects models indicated that the two groups did not differ on adherence during either the intervention (b = − .05, SE = .07, p = .49) or follow-up (b = − .03, SE = .05, p = .57).
Viral load Patients in both the MT and HC groups showed improvements in viral load data. With viral suppression operationalized as < 500 copies/mL, there was a time-by-condition trend from baseline to post-intervention, F (1, 35) = 4.07, p = .051, such that the proportion of MT patients who were suppressed increased (from 67% to 77%) while it decreased in the HC group (from 91% to 81%). This trend was not sustained, as proportions suppressed at 3-month follow-up (MT = 70%, HC = 95%) regressed toward baseline levels for both conditions.
Sexual Risk Behavior
Patients in the MT condition reported a higher proportion of condom protected events (Ms = 57%, 100%, and 71%) relative to patients in the HC condition (Ms = 32%, 49%, and 43%). Assumption of sphericity was violated (p = .015) and the group-by-time interaction was non-significant, Greenhouse–Geisser F (2, 22) = 0.89, p = .387.
The occurrence of new STIs was rare; therefore, we combined STIs identified with laboratory testing with STIs reported in the medical chart. Overall, the proportion of STIs at follow-up was 9.1% in HC, and 5% in MT (p = .607).
Hypothesized Mediators
We observed a consistent pattern of improvement in both conditions over time. Reductions were observed in anxiety (HC = 7.5, 5.0, 4.5; MT = 9.3, 7.9, 7.2), depression (HC = 8.6, 5.7, 5.2; MT = 9.8, 8.8, 6.9), perceived stress (HC = 5.9, 5.6, 5.7; MT = 6.9, 6.1, 5.8), and impulsivity (HC = 17.5, 15.6, 16.5; MT = 18.2, 17.8, 16.1). While group-by-time interactions were not significant, there was a significant within-subjects effect of time for anxiety, F (2, 74) = 4.59, p = .021, depression, F (2, 74) = 6.13, p = .003, and impulsivity F (2, 74) = 4.90, p = .010. Mindfulness scores improved in both conditions over time (HC = 49.1, 52.7, and 52.2; MT = 47.7, 53.1, and 53.1). Similarly, while the group-by-time interaction was non-significant, a significant within-subjects effect for time was observed, F (2, 74) = 11.06, p < .001.
Qualitative data The data obtained during interviews corroborated quantitative changes. Patients in both groups reported improvements in medication adherence. Patients correctly inferred that a purpose of the study was to improve adherence. As an example, when asked what the study was about, one patient responded: “I think it was to help get me on track with my HIV meds.” A second patient responded: “This study was about how … to be able to continue to take my medication, not to lose a time or to lose a date. The study was about if I continue to take my medication I would be healthy enough.”
Several patients also thought that the unannounced pill count calls were a part of the intervention and credited the calls with helping to improve adherence. “[The pill counts] influenced me because, first of all, I was feeling sickly, or whatever. I just wasn’t, I wasn’t feeling right. So, when she used to call me, she used to do the pill count [and] I wasn’t taking them. Like some bottles had more [pills] than others, I was like, ‘this didn’t add up’ or whatever. So I started putting it in my weekly pill box, and that reminded me to take them every day!… I put them in a spot where I could see them every day, so when she called [instead of] ‘oh my God, I can’t find them;’ they would be right there. And I see the pills, so I, that made me take them. Yeah, she really, that really helped.”
A second patient offered: “[The pill count caller] helped too, with trying to keep me on track with those pills.” And a third stated: “I found [the pill count calls] very much helpful. It’s actually helped me stay on track with taking my medication every day. So that to me was awesome.”
With respect to the psychological effects of the interventions, patients described changes associated with MT: “As time went on and we had more appointments, and we went over it again, there were things that I was doing that I didn’t realize I was doing. You know. I was controlling my breathing. I was moving a lot of my feeling and my sensations from my nose down to my fingertips and down to my toes and back up to my chest. And breathing in calmly and doing things I never, you know, took the time to pay attention to before.”
Participants in MT also noted positive changes in their daily life, such as: “I am more mindful of everything that’s happening. I pay more attention to what’s going on I guess. I didn’t think I didn’t pay that much attention, but before I talked to [mindfulness instructor] to what I do now is like two different animals!”
Participants in the HC also reported making changes in their life, such as, “I am trying to take care of myself better, because this whole study gave me insight. On my pills, my doctors, and my eating habits. I’m not completely excellent at it, but I’m making progress.”
Discussion
To our knowledge, this study is the first to explore telephone-delivery of MT to improve medication adherence and reduce sexual risk behavior among PLWH. The results document a complex pattern regarding the feasibility and acceptability of telephone-delivered MT for PLWH. With respect to feasibility, 55% of those assigned to MT group completed at least half of their scheduled sessions. This completion rate was lower than expected, based on what has been observed during in-person MT with PLWH (e.g., 75% in prior studies [25, 54]), and lower than the rate we observed for the health coaching condition (i.e., 86%). Most commonly, patients missed sessions due to life stress, similar to findings from a study that was conducted in a resource-constrained environment [24]. Most patients reported that they liked telephone-delivery but one patient voiced a preference for face-to-face training; importantly, no patient reported concerns about their instructor or any adverse experience.
To fully benefit from MT, trainees need to invest a considerable amount of time and personal effort [22]. They also need a quiet space for formal mindfulness practice. Several patients described busy schedules and chaotic home environments that did not permit them to take telephone calls or practice mindfulness regularly. Patients with the most stressful life circumstances—those who might have the most to gain from MT—also find it most difficult to create the conditions needed for receiving telephone calls and engaging in regular practice. It is common for people learning to practice mindfulness to initially report they sometimes find the practice challenging or difficult to fit into busy schedules [55]. These “start-up” challenges can undermine a person’s willingness and ability to persevere with the practice, especially in the early stages of training. It is likely that such challenges are even greater given the background life circumstances of many PLWH.
Given the challenges that some participants described, research might consider ways to further adapt MT to the life circumstances of PLWH. One possibility might be to employ a hybrid approach that blends in-person training with telephone sessions. For example, it might be useful to schedule one or more initial in person sessions to establish a therapeutic relationship in person, correct potential misunderstandings, provide tailored instructions, address patient concerns, and plan for home-based practice. The concepts and skills associated with MT can seem foreign and certainly novel, and more time and orientation to key concepts may be necessary. Once a patient is comfortable with their instructor and more familiar with the concepts and practice of mindfulness, subsequent sessions could be completed by telephone to minimize transportation and other external barriers. Previous research provides a useful precedent [24]. In that study, the lack of private space (in an impoverished, endemic HIV setting) led to a key adaptation of the intervention, namely, a greater focus on informal practice and mindfulness of daily life activities.
Despite these implementation challenges, patients reported liking and benefiting from MT. (Only one patient mentioned a dislike of MT; this participant found the silence uncomfortable). Indeed, as displayed in Table 3, most patients rated the intervention and the instructors positively, found MT helpful, and continued to use the study recordings. Interestingly, when interviewed at follow-up, even those patients who attended fewer than 50% of the sessions reported that they continued to use the MT recordings.
Overall, the feasibility and acceptability data suggest that attending MT sessions, even by telephone, and practicing mindfulness was challenging for some patients but that most of them generally liked the experience and found it acceptable. For those PLWH who can create the conditions needed for practice and tolerate start-up challenges, MT offers a promising self-care and stress management approach.
A secondary goal of this exploratory study was to explore the effects of MT on medication adherence and sexual risk behaviors. With respect to medication adherence, patients in both conditions reported fewer missed days of medication taking from baseline through the follow-up period. These self-reports were partially corroborated by the unannounced pill count assessments and improvements in viral suppression. Plotted data from the unannounced pill count calls (Fig. 2) showed a U-shaped curve reflective of reduced medication adherence during the intervention phase of the study for both groups. Viral suppression also declined during the intervention phase for the HC group. Both groups showed improvement from the intervention phase to the follow-up phase. We have no compelling explanation for the decline in adherence during the intervention phase and hypothesize that this result is likely spurious. Additional research is needed with larger samples to further investigate the effects of MT on medication adherence.
With respect to sexual risk behavior, patients who received MT increased the proportion of times they used condoms relative to patients in the HC condition (71% vs. 43%) but the observed effects were not statistically significant. The incidence of new infections was also lower in the MT group (5.0%) compared to the HC group (9.1%). We hasten to add that the groups did not differ significantly (likely due to the small sample size) but note that the sexual risk reduction results were in the expected direction.
A tertiary goal of this study was to assess the effects of MT on the hypothesized psychological antecedents (mediators) of behavioral change. The effects of MT were consistently in the predicted direction. Thus, patients in the MT group reported fewer symptoms of depression and anxiety as well as lower perceived stress and impulsivity. Mindfulness levels also increased post-intervention. That said, there were no between-group differences in these effects. These results are consistent with those of a recent trial of mindfulness-based stress reduction for PLWH that showed no differences between MBSR and a self-management skills control condition on depression, perceived stress, and mindfulness; [54] significant effects were seen only for positive affect. Similar findings were reported in a meta-analysis showing low or insufficient evidence that meditation programs are more effective than active comparison conditions (e.g., exercise, progressive muscle relaxation, cognitive-behavioral therapy, and others) [24]. In regard to the lack of group differences in self-reported mindfulness, which increased in both conditions, prior research has shown no between-group effects on self-reported mindfulness for randomized controlled trials using an active control condition [56]. Such results are often explained by concerns about the validity and usefulness of extant mindfulness questionnaires; these concerns point to the need for more valid and objective assessments of mindfulness skills [57].
Comparisons of the MT and the HC groups are clearly preliminary given the early stage of this research and the small sample size recruited for this study. With respect to future research, we note that the use of a potent comparison condition can make finding an effect more difficult. We used health coaching as a time- and attention-matched control group. Health coaching is an increasingly popular intervention approach [58, 59] with mounting empirical support. We identified topics for HC from our formative research [28], developed a training manual, and delivered the intervention with fidelity using highly trained clinical psychology trainees. Even though the health coaching protocol prohibited discussion of mental health issues (including mindfulness), and fidelity checks and supervision confirmed that the health coaches followed the protocols, it is possible that the psychology trainees who served as health coaches enacted health coaching differently than a less well-trained health coach might have. It is also possible that discussion of health topics did, indirectly, improve mindfulness.
Overall, health coaching performed well with respect to its feasibility and acceptability. Patients in the HC condition responded well to the telephone-delivered intervention. This was not surprising, as the content for the coaching was developed using focus groups of PLWH to ensure that this condition would be meaningful for patients. Patients in HC described the program as helpful and reported continued use of the coaching tips, including healthy eating and sun safety behavior. A potential explanation for the greater call completion and favorability of HC is that the health behavior topics are more relatable and immediately useful to PLWH, and the sessions and practice required less “work” compared to learning a new skill (as required with the MT). Future research on health coaching as an active intervention is warranted.
There are several alternative explanations for the muted effects observed in this exploratory study. First, with respect to between-groups effects, we used a small sample of PLWH with limited statistical power. Second, the dose and duration of the MT may have been inadequate. Third, finding an effect in a research study can be challenging due to “assessment reactivity.” Consistent with this possibility, some patients stated during follow-up interviews that the unannounced pill counts helped them to remain adherent; these patients thought the pill count calls were part of the intervention. Assessment reactivity can make it difficult to isolate the effects of an intervention from efforts to measure those effects.
The current study used telephone-delivery to mitigate the potential barriers of attending in-person interventions (e.g., unstable housing, lack of access to reliable transportation, inflexible family and work responsibilities). Prior studies have demonstrated feasibility of this intervention modality with other chronic health populations (e.g., cardiac patients [30]). The results of this study corroborate prior work and confirm our expectation that this modality would be feasible and acceptable. Although one patient expressed a preference for in-person MT sessions, most patients appreciated the convenience of attending by telephone. Several patients expressed an interest in meeting their instructor or coach, as they had developed appreciation for and attachment to their interventionist.
The results of this study should be interpreted with its strengths and limitations in mind. Strengths of the study include preliminary formative research with the patient population; use of a controlled design; the structural equivalence of the comparison condition; use of written assessment and intervention protocols; blinding of assessors and interventionists to the study hypotheses; delivery of the theoretically-guided interventions with fidelity by skilled and experienced interventionists; use of a comprehensive, reliable, and valid evaluation system (with self-report, objective, and biological outcomes); and use of mixed methods including qualitative as well as quantitative assessments.
Several limitations should also be acknowledged. First, this was an exploratory study with a small sample size; thus, the study was not powered to detect group differences or examine mediation effects. A larger, randomized controlled trial examining efficacy of telephone-delivered MT is needed. Second, the findings are limited in generalizability by the study inclusion criteria and use of a single recruitment site. Third, with respect to medication non-adherence, we allowed patients with relatively mild levels of non-adherence (i.e., viral load of > 20 copies/mL) to participate in the trial. This decision likely made it more difficult to observe improvement on this outcome (i.e., a “floor” effect). Fourth, some of the outcomes and all of the mediators relied upon self-report. Such measures can be influenced by both social demand (e.g., the desire to please the assessor and investigators) and cognitive limitations (e.g., memory constraints). To minimize these potential biases, we used computerized assessments, assessors who were blinded to study hypotheses, assessments of shorter intervals, and multimodal assessments (i.e., supplementing self-report with objective measures and biomarkers); nonetheless, the limitations of self-report must be acknowledged.
In summary, this study shows that telephone-based mindfulness training is feasible and acceptable to many PLWH. For some PLWH, MT may require adaptation to optimize its acceptability. Providers in HIV healthcare settings should take this into consideration when recommending mindfulness training to patients. Future research might examine patient characteristics associated with acceptability of MT for PLWH so that interventions can be targeted appropriately and adapted as needed. The study results also suggest that telephone-delivered health coaching is feasible and acceptable as an alternative intervention. For both MT and health coaching, telephone delivery can overcome some of the barriers to participating in psychosocial interventions and should be explored further for PLWH.
References
Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis. 2013;26(1):17–25.
Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE. 2013;8(12):e81355.
Jiamsakul A, Kariminia A, Althoff KN, et al. HIV viral load suppression in adults and children receiving antiretroviral therapy-results from the IeDEA collaboration. J Acquir Immune Defic Syndr. 2017;76(3):319.
Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164–71.
Bradley H, Hall HI, Wolitski RJ, et al. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV—United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63(47):1113.
Atkinson MJ, Petrozzino JJ. An evidence-based review of treatment-related determinants of patients’ nonadherence to HIV medications. AIDS Patient Care STDs. 2009;23(11):903–14.
White JM, Gordon JR, Mimiaga MJ. The role of substance use and mental health problems in medication adherence among HIV-infected MSM. LGBT Health. 2014;1(4):319–22.
Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119–43.
Crockett KB, Kalichman SC, Kalichman MO, Cruess DG, Katner HP. Experiences of HIV-related discrimination and consequences for internalised stigma, depression and alcohol use. Psychol Health. 2019;34:796–810.
Kalichman SC, Grebler T. Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS. Psychosom Med. 2010;72(8):810.
Crawford ND, Galea S, Ford CL, Latkin C, Link BG, Fuller C. The relationship between discrimination and high-risk social ties by race/ethnicity: examining social pathways of HIV risk. J Urban Health. 2014;91(1):151–61.
Hurd NM, Varner FA, Caldwell CH, Zimmerman MA. Does perceived racial discrimination predict changes in psychological distress and substance use over time? An examination among Black emerging adults. Dev Psychol. 2014;50(7):1910.
Jones J, Sullivan PS. Impulsivity as a risk factor for HIV transmission in men who have sex with men: a delay discounting approach. J Homosex. 2015;62(5):588–603.
Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2014;17(1):530.
Simons JS, Maisto SA, Wray TB. Sexual risk taking among young adult dual alcohol and marijuana users. Addict Behav. 2010;35(5):533–6.
Kelly JA, St Lawrence JS, Amirkhanian YA, et al. Levels and predictors of HIV risk behavior among Black men who have sex with men. AIDS Educ Prev. 2013;25(1):49–61.
Friedman MR, Wei C, Klem ML, Silvestre AJ, Markovic N, Stall R. HIV infection and sexual risk among men who have sex with men and women (MSMW): a systematic review and meta-analysis. PLoS ONE. 2014;9(1):e87139.
Crepaz N, Marks G, Liau A, et al. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis. AIDS. 2009;23(13):1617–29.
Van Dam NT, van Vugt MK, Vago DR, et al. Mind the hype: a critical evaluation and prescriptive agenda for research on mindfulness and meditation. Perspect Psychol Sci. 2018;13(1):36–61.
Creswell JD. Mindfulness interventions. Annu Rev Psychol. 2017;68:491–516.
Salmoirago-Blotcher E, Carey MP. Can mindfulness training improve medication adherence? Integrative review of the current evidence and proposed conceptual model. Explore. 2018;14(1):59–65.
Scott-Sheldon LA, Balletto BL, Donahue ML, et al. Mindfulness-based interventions for adults living with HIV/AIDS: a systematic review and meta-analysis. AIDS Behav. 2019;23(1):60–75.
Creswell JD, Myers HF, Cole SW, Irwin MR. Mindfulness meditation training effects on CD4 + T lymphocytes in HIV-1 infected adults: a small randomized controlled trial. Brain Behav Immun. 2009;23(2):184–8.
McIntyre T-L, Elkonin D, de Kooker M, Magidson JF. The application of mindfulness for individuals living with HIV in South Africa: a hybrid effectiveness-implementation pilot study. Mindfulness. 2018;9(3):871–83.
Gonzalez-Garcia M, Ferrer MJ, Borras X, et al. Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV infection. AIDS Behav. 2014;18(4):676–85.
Riley KE, Kalichman S. Mindfulness-based stress reduction for people living with HIV/AIDS: preliminary review of intervention trial methodologies and findings. Health Psychol Rev. 2015;9(2):224–43.
Davidson RJ, Kaszniak AW. Conceptual and methodological issues in research on mindfulness and meditation. Am Psychol. 2015;70(7):581.
Rosen RK, McGarrity LA, Salmoirago-Blotcher E, Rich C, Rana A, Carey MP. Telephone-delivered mindfulness training for people living with HIV: a qualitative 360 inquiry. AIDS Behav. 2017;21(11):3194–201.
Salmoirago-Blotcher E, Carmody J, Yeh G, Crawford S, Rosenthal L, Ockene I. Design and methods for a pilot study of a phone-delivered, mindfulness-based intervention in patients with implantable cardioverter defibrillators. Evid Based Complement Alternat Med. 2012;2012:972106.
Salmoirago-Blotcher E, Crawford SL, Carmody J, et al. Phone-delivered mindfulness training for patients with implantable cardioverter defibrillators: results of a pilot randomized controlled trial. Ann Behav Med. 2013;46(2):243–50.
Salmoirago-Blotcher E, Rich C, Rosen RK, Dunsiger S, Rana A, Carey MP. Phone-delivered mindfulness training to promote medication adherence and reduce sexual risk behavior among persons living with HIV: design and methods. Contemp Clin Trials. 2017;53:162–70.
Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess. 1988;52(1):30–41.
Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcoholism. 2007;31(2):185–99.
Skinner HA. The drug abuse screening test. Addict Behav. 1982;7(4):363–71.
Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plan. 1979;2(3):197–207.
Simoni JM, Huh D, Wang Y, et al. The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: findings from the MACH14 study. AIDS Behav. 2014;18(12):2285–90.
Wilson IB, Fowler FJ, Cosenza CA, et al. Cognitive and field testing of a new set of medication adherence self-report items for HIV care. AIDS Behav. 2014;18(12):2349–58.
Fredericksen R, Feldman B, Brown T, et al. Unannounced telephone-based pill counts: a valid and feasible method for monitoring adherence. AIDS Behav. 2014;18(12):2265–73.
Kalichman SC, Amaral CM, Cherry C, et al. Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008;9(5):298–308.
Kalichman SC, Amaral CM, Stearns H, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007;22(7):1003.
Zhang Q, Qiao S, Yang X, Li X. Antiretroviral concentration in hair as a measure for antiretroviral medication adherence: a systematic review of global literature. AIDS Behav. 2019. https://doi.org/10.1007/s10461-019-02460-5.
Carey MP, Senn TE, Walsh JL, et al. Evaluating a brief, video-based sexual risk reduction intervention and assessment reactivity with STI clinic patients: results from a randomized controlled trial. AIDS Behav. 2015;19(7):1228–46.
Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.
Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613–21.
Cohen S. Perceived stress in a probability sample of the United States. 1988.
Gu J, Strauss C, Crane C, et al. Examining the factor structure of the 39-item and 15-item versions of the Five Facet Mindfulness Questionnaire before and after mindfulness-based cognitive therapy for people with recurrent depression. Psychol Assess. 2016;28(7):791.
Steinberg L, Sharp C, Stanford MS, Tharp AT. New tricks for an old measure: the development of the Barratt Impulsiveness Scale-Brief (BIS-Brief). Psychol Assess. 2013;25(1):216.
Broadhead WE, Leon AC, Weissman MM, et al. Development and validation of the SDDS-PC screen for multiple mental disorders in primary care. Arch Fam Med. 1995;4(3):211.
Morris NS, MacLean CD, Chew LD, Littenberg B. The Single Item Literacy Screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pract. 2006;7(1):21.
Bellg AJ, Borrelli B, Resnick B, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23(5):443.
Kabat-Zinn J. Mindfulness-based stress reduction (MBSR). Construct Hum Sci. 2003;8(2):73.
American Heart Association. Healthy Living. 2018; https://www.heart.org/en/healthy-living.
QSR International Pty Ltd. NVivo qualitative data analysis software. Version 10, ed 2012.
Hecht FM, Moskowitz JT, Moran P, et al. A randomized, controlled trial of mindfulness-based stress reduction in HIV infection. Brain Behav Immun. 2018;73:331–9.
Davis JM, Fleming MF, Bonus KA, Baker TB. A pilot study on mindfulness based stress reduction for smokers. BMC Complement Altern Med. 2007;7(1):2.
Visted E, Vøllestad J, Nielsen MB, Nielsen GH. The impact of group-based mindfulness training on self-reported mindfulness: a systematic review and meta-analysis. Mindfulness. 2015;6(3):501–22.
Grossman P. On measuring mindfulness in psychosomatic and psychological research. J Psychosom Res. 2008;64:405–8.
Wolever RQ, Dreusicke MH. Integrative health coaching: a behavior skills approach that improves HbA1c and pharmacy claims-derived medication adherence. BMJ Open Diabetes Res Care. 2016;4(1):e000201.
Wolever RQ, Simmons LA, Sforzo GA, et al. A systematic review of the literature on health and wellness coaching: defining a key behavioral intervention in healthcare. Glob Adv Health Med. 2013;2(4):38–57.
Acknowledgements
This project was funded by a grant from the National Centers for Complementary and Integrative Health (R34-AT008930) to Drs. Carey and Salmoirago-Blotcher. The funding agency had no involvement in the study design; in the collection, analysis and interpretation of data; in the writing of this report; and in the decision to submit this article for publication. We thank the patient participants, the Immunology Center staff at The Miriam Hospital, the mindfulness instructors and health coaches, and the pill count assessors for their contributions to this research. A special thank you to Moira Kalichman and Seth Kalichman for their guidance regarding the use of the unannounced pill count assessment protocol.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Carey, M.P., Dunne, E.M., Norris, A. et al. Telephone-Delivered Mindfulness Training to Promote Medication Adherence and Reduce Sexual Risk Behavior Among Persons Living with HIV: An Exploratory Clinical Trial. AIDS Behav 24, 1912–1928 (2020). https://doi.org/10.1007/s10461-019-02768-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-019-02768-2